<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>American Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0002-9297</issn>
<issn pub-type="epub">1537-6605</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28669404</article-id>
<article-id pub-id-type="pmc">5501773</article-id>
<article-id pub-id-type="publisher-id">S0002-9297(17)30200-8</article-id>
<article-id pub-id-type="doi">10.1016/j.ajhg.2017.05.013</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Acuna-Hidalgo</surname>
<given-names>Rocio</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sengul</surname>
<given-names>Hilal</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Steehouwer</surname>
<given-names>Marloes</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van de Vorst</surname>
<given-names>Maartje</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vermeulen</surname>
<given-names>Sita H.</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kiemeney</surname>
<given-names>Lambertus A.L.M.</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Veltman</surname>
<given-names>Joris A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gilissen</surname>
<given-names>Christian</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hoischen</surname>
<given-names>Alexander</given-names>
</name>
<email>alexander.hoischen@radboudumc.nl</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 10, 6525 GA Nijmegen, the Netherlands</aff>
<aff id="aff2"><label>2</label>Department of Human Genetics, Donders Institute of Neuroscience, Radboud University Medical Center, Geert Grooteplein 10, 6525 GA Nijmegen, the Netherlands</aff>
<aff id="aff3"><label>3</label>Radboud Institute for Health Sciences, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands</aff>
<aff id="aff4"><label>4</label>Institute of Genetic Medicine, International Centre for Life, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK</aff>
<aff id="aff5"><label>5</label>Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author <email>alexander.hoischen@radboudumc.nl</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>06</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>101</volume>
<issue>1</issue>
<fpage>50</fpage>
<lpage>64</lpage>
<history>
<date date-type="received">
<day>29</day>
<month>3</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>5</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 American Society of Human Genetics.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>American Society of Human Genetics</copyright-holder>
</permissions>
<abstract id="abs0010">
<p>Clonal hematopoiesis results from somatic mutations in hematopoietic stem cells, which give an advantage to mutant cells, driving their clonal expansion and potentially leading to leukemia. The acquisition of clonal hematopoiesis-driver mutations (CHDMs) occurs with normal aging and these mutations have been detected in more than 10% of individuals ≥65 years. We aimed to examine the prevalence and characteristics of CHDMs throughout adult life. We developed a targeted re-sequencing assay combining high-throughput with ultra-high sensitivity based on single-molecule molecular inversion probes (smMIPs). Using smMIPs, we screened more than 100 loci for CHDMs in more than 2,000 blood DNA samples from population controls between 20 and 69 years of age. Loci screened included 40 regions known to drive clonal hematopoiesis when mutated and 64 novel candidate loci. We identified 224 somatic mutations throughout our cohort, of which 216 were coding mutations in known driver genes (<italic>DNMT3A</italic>, <italic>JAK2</italic>, <italic>GNAS</italic>, <italic>TET2</italic>, and <italic>ASXL1</italic>), including 196 point mutations and 20 indels. Our assay’s improved sensitivity allowed us to detect mutations with variant allele frequencies as low as 0.001. CHDMs were identified in more than 20% of individuals 60 to 69 years of age and in 3% of individuals 20 to 29 years of age, approximately double the previously reported prevalence despite screening a limited set of loci. Our findings support the occurrence of clonal hematopoiesis-associated mutations as a widespread mechanism linked with aging, suggesting that mosaicism as a result of clonal evolution of cells harboring somatic mutations is a universal mechanism occurring at all ages in healthy humans.</p>
</abstract>
<kwd-group id="kwrds0010">
<title>Keywords</title>
<kwd>age-related clonal hematopoiesis</kwd>
<kwd>somatic mutations</kwd>
<kwd>mosaicism</kwd>
<kwd>DNMT3A</kwd>
<kwd>ultra-sensitive sequencing</kwd>
<kwd>smMIPs</kwd>
</kwd-group>
</article-meta>
<notes>
<p id="misc0010">Published: June 29, 2017</p>
</notes>
</front>
</article>
</pmc-articleset>